Skip to main content

Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomas

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Saglam A, Hayran M, Uner AH, Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomas. APMIS 2008;116:791–800.

Multidrug resistance (MDR) is defined as resistance of tumor cells to a wide spectrum of structurally and functionally unrelated drugs. One of the most important mechanisms in mediating MDR is that involving cellular drug efflux transporters. Drug resistance is a common and formidable obstacle to therapy in mature T/NK-cell lymphomas and the MDR phenotype is thought to be one of the contributing mechanisms. In this study we assessed the immunohistochemical expression of P-gp (P-glycoprotein), MRP-1 (multidrug resistance associated protein 1), BCRP (breast cancer resistance protein) and LRP (lung resistance protein) in 45 mature T/NK-cell lymphomas diagnosed at our hospital. We detected P-gp expression in 31% (13/42), MRP-1 expression in 74% (31/42), BCRP in 78% (32/ 41) and LRP in 59% (26/44) of the cases. These findings show that our T/NK-cell lymphoma cases display high frequency of MDR protein expression.

Keywords: P-glycoprotein; T-cell lymphoma; breast cancer resistance protein; lung resistance protein; multidrug resistance associated protein

Document Type: Original Article

DOI: http://dx.doi.org/10.1111/j.1600-0463.2008.00974.x

Affiliations: 1: Pathology 2: Preventive Oncology, Oncology Institute, Hacettepe University Faculty of Medicine, Ankara,Turkey

Publication date: September 1, 2008

mksg/apm/2008/00000116/00000009/art00004
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more